Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00513903 · ClinicalTrials.gov registry record · Phase 3
Expanding the Role of Pharmacists in Treating Persons With Cardiovascular or Lung Diseases
A Phase 3 study, sponsored by University of Iowa.
- Completed
- Registry status
- Phase 3
- Development phase
- 954
- Enrollment target
NCT00513903 is a Phase 3 study that has completed, run by University of Iowa. The registered enrollment target is 954 participants.
The verdict
NCT00513903, a Phase 3 study, has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 954 participants
- Enrollment target
Study Summary
This study will test whether enhanced continuity of pharmacy care that includes increased communication between inpatient and outpatient settings will improve the appropriateness of medication therapy and reduce the number of serious adverse drug events, hospitalizations and unscheduled office visits in vulnerable patients with cardiovascular disease, pulmonary disease or diabetes.
Interventions
- BEHAVIORAL Minimal intervention
- BEHAVIORAL Enhanced Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 954 participants |
| Start Date | 2008-03 |
| Est. Completion | 2012-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00513903
The ClinicalTrials.gov registry entry for NCT00513903 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 954 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Minimal intervention is the first listed.
NCT00513903 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00513903 about?
NCT00513903 is a clinical study titled "Expanding the Role of Pharmacists in Treating Persons With Cardiovascular or Lung Diseases". This study will test whether enhanced continuity of pharmacy care that includes increased communication between inpatient and outpatient settings will improve the appropriateness of medication therapy and reduce the number of serious adverse drug events, hospitalizations and unscheduled office visit...
What is the current status of trial NCT00513903?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 954 participants. The study started on 2008-03. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00513903?
The interventions under investigation include: Minimal intervention (BEHAVIORAL), Enhanced Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00513903?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.